Lipid Nanoparticle Delivery of siRNA to Osteocytes Leads to Effective Silencing of SOST and Inhibition of Sclerostin In Vivo
Sclerostin is a protein secreted by osteocytes that is encoded by the SOST gene; it decreases bone formation by reducing osteoblast differentiation through inhibition of the Wnt signaling pathway. Silencing the SOST gene using RNA interference (RNAi) could therefore be an effective way to treat oste...
Saved in:
Main Authors: | Genc Basha (Author), Mina Ordobadi (Author), Wilder R Scott (Author), Andrew Cottle (Author), Yan Liu (Author), Haitang Wang (Author), Pieter R Cullis (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Expression of SOST/sclerostin in compressed periodontal ligament cells
by: Masae Ueda, et al.
Published: (2016) -
SOST/Sclerostin impairs the osteogenesis and angiogesis in glucocorticoid-associated osteonecrosis of femoral head
by: Junming Huang, et al.
Published: (2024) -
Advances in Lipid Nanoparticles for siRNA Delivery
by: Sam Chen, et al.
Published: (2013) -
PPARG in osteocytes controls cell bioenergetics and systemic energy metabolism independently of sclerostin levels in circulation
by: Sudipta Baroi, et al.
Published: (2024) -
Strategies for Improving siRNA-Induced Gene Silencing Efficiency
by: Fatemeh Safari, et al.
Published: (2017)